Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Phase 1 Unknown
10 enrolled
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Phase 1 Unknown
168 enrolled
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Phase 1 Unknown
24 enrolled
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1 Unknown
189 enrolled
68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study
Phase 1 Unknown
50 enrolled
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Phase 1 Unknown
96 enrolled
AMT-151 in Patients With Selected Advanced Solid Tumours
Phase 1 Unknown
30 enrolled
IMMUNOs-SBRT
Phase 1 Unknown
92 enrolled
The Application of Novel Oncolytic Virus in Late Stage Solid Tumors
Phase 1 Unknown
24 enrolled
CAT_PB
Phase 1 Unknown
500 enrolled
A Study Of IMM47 In Subjects With Advanced Solid Tumors
Phase 1 Unknown
48 enrolled
Phase 1 First-in-human Study of JS014
Phase 1 Unknown
60 enrolled
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
Phase 1 Unknown
16 enrolled
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Phase 1 Unknown
1 enrolled
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
Phase 1 Unknown
50 enrolled
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Phase 1 Unknown
156 enrolled
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Phase 1 Unknown
29 enrolled
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
100 enrolled
NWTTPS
Phase 1 Unknown
30 enrolled
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors
Phase 1 Unknown
23 enrolled
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
Phase 1 Unknown
48 enrolled
IMM40H Phase I Dose Escalation and Expansion
Phase 1 Unknown
16 enrolled
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Unknown
133 enrolled
MICROBIOME
Phase 1 Unknown
120 enrolled
A Study of Injection HB0025 in Patients With Advanced Solid Tumors
Phase 1 Unknown
154 enrolled
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor
Phase 1 Unknown
60 enrolled
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
80 enrolled
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
Phase 1 Unknown
48 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
Phase 1 Unknown
30 enrolled
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Phase 1 Unknown
272 enrolled
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Phase 1 Unknown
70 enrolled
GAMING
Phase 1 Unknown
20 enrolled
Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors
Phase 1 Unknown
15 enrolled
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
Phase 1 Unknown
12 enrolled
A Study of PSB205 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
64 enrolled
KYPHO-IORT
Phase 1 Unknown
10 enrolled
A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms
Phase 1 Unknown
75 enrolled
IORT
Phase 1 Unknown
12 enrolled
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
Phase 1 Unknown
30 enrolled
An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment
Phase 1 Unknown
30 enrolled
PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies
Phase 1 Unknown
37 enrolled
Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors
Phase 1 Unknown
30 enrolled
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Phase 1 Unknown
12 enrolled
Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
206 enrolled
GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma
Phase 1 Unknown
30 enrolled
Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors
Phase 1 Unknown
134 enrolled
Tolerance and Pharmacokinetics of TQB2450
Phase 1 Unknown
50 enrolled
Tolerance and Pharmacokinetics of TQ-B3233
Phase 1 Unknown
50 enrolled